Clinical Trial Update: A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial compares neoadjuvant weekly paclitaxel alone to paclitaxel plus weekly carboplatin in women with large operable or locally advanced t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Triple Negative Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING